Jane Street Group LLC Increases Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Jane Street Group LLC increased its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 5.5% in the 3rd quarter, Holdings Channel reports. The fund owned 11,846 shares of the company’s stock after buying an additional 616 shares during the quarter. Jane Street Group LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $836,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. FMR LLC increased its position in iShares U.S. Pharmaceuticals ETF by 10.9% during the third quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after acquiring an additional 1,338 shares during the last quarter. Marshall Wace LLP purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth $422,000. Mercer Global Advisors Inc. ADV increased its position in shares of iShares U.S. Pharmaceuticals ETF by 7.4% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock valued at $254,000 after purchasing an additional 266 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 7.3% in the second quarter. Commonwealth Equity Services LLC now owns 38,172 shares of the company’s stock valued at $2,532,000 after acquiring an additional 2,589 shares during the period. Finally, Sequoia Financial Advisors LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at approximately $204,000.

iShares U.S. Pharmaceuticals ETF Stock Up 0.6 %

IHE stock opened at $65.72 on Thursday. iShares U.S. Pharmaceuticals ETF has a twelve month low of $61.14 and a twelve month high of $72.94. The business’s fifty day simple moving average is $68.04 and its two-hundred day simple moving average is $69.02. The firm has a market cap of $663.77 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.